First Time Loading...

Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 28.39 EUR 1.07% Market Closed
Updated: Mar 1, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Bayer AG

Revenue
47.8B EUR
Cost of Revenue
-20B EUR
Gross Profit
27.7B EUR
Operating Expenses
-27.9B EUR
Operating Income
-145m EUR
Other Expenses
-3.5B EUR
Net Income
-3.7B EUR

Margins Comparison
Bayer AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Bayer AG
XETRA:BAYN
27.9B EUR
58%
0%
-8%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-3%
-83%
-79%
US
Eli Lilly and Co
NYSE:LLY
734.4B USD
79%
30%
15%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
3%
-4%
DK
Novo Nordisk A/S
CSE:NOVO B
3.8T DKK
85%
45%
36%
US
Johnson & Johnson
NYSE:JNJ
389.4B USD
69%
18%
41%
US
Merck & Co Inc
NYSE:MRK
323.1B USD
77%
10%
1%
CH
Roche Holding AG
SIX:ROG
186.2B CHF
74%
33%
20%
CH
Novartis AG
SIX:NOVN
184.9B CHF
74%
27%
32%
UK
AstraZeneca PLC
LSE:AZN
156.1B GBP
82%
19%
13%
US
Pfizer Inc
NYSE:PFE
150.8B USD
70%
22%
4%
Country DE
Market Cap 27.9B EUR
Gross Margin
58%
Operating Margin
0%
Net Margin
-8%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Operating Margin
-83%
Net Margin
-79%
Country US
Market Cap 734.4B USD
Gross Margin
79%
Operating Margin
30%
Net Margin
15%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Operating Margin
3%
Net Margin
-4%
Country DK
Market Cap 3.8T DKK
Gross Margin
85%
Operating Margin
45%
Net Margin
36%
Country US
Market Cap 389.4B USD
Gross Margin
69%
Operating Margin
18%
Net Margin
41%
Country US
Market Cap 323.1B USD
Gross Margin
77%
Operating Margin
10%
Net Margin
1%
Country CH
Market Cap 186.2B CHF
Gross Margin
74%
Operating Margin
33%
Net Margin
20%
Country CH
Market Cap 184.9B CHF
Gross Margin
74%
Operating Margin
27%
Net Margin
32%
Country UK
Market Cap 156.1B GBP
Gross Margin
82%
Operating Margin
19%
Net Margin
13%
Country US
Market Cap 150.8B USD
Gross Margin
70%
Operating Margin
22%
Net Margin
4%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Bayer AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Bayer AG
XETRA:BAYN
27.9B EUR
-10%
-3%
0%
0%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-441%
-47%
-108%
-64%
US
Eli Lilly and Co
NYSE:LLY
734.4B USD
49%
9%
30%
16%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
-2%
2%
2%
DK
Novo Nordisk A/S
CSE:NOVO B
3.8T DKK
88%
30%
79%
36%
US
Johnson & Johnson
NYSE:JNJ
389.4B USD
47%
20%
12%
10%
US
Merck & Co Inc
NYSE:MRK
323.1B USD
1%
0%
7%
1%
CH
Roche Holding AG
SIX:ROG
186.2B CHF
40%
13%
30%
23%
CH
Novartis AG
SIX:NOVN
184.9B CHF
28%
14%
16%
14%
UK
AstraZeneca PLC
LSE:AZN
156.1B GBP
16%
6%
13%
11%
US
Pfizer Inc
NYSE:PFE
150.8B USD
2%
1%
8%
16%
Country DE
Market Cap 27.9B EUR
ROE
-10%
ROA
-3%
ROCE
0%
ROIC
0%
Country JP
Market Cap 776 550.9T JPY
ROE
-441%
ROA
-47%
ROCE
-108%
ROIC
-64%
Country US
Market Cap 734.4B USD
ROE
49%
ROA
9%
ROCE
30%
ROIC
16%
Country UK
Market Cap 440.4B GBP
ROE
-4%
ROA
-2%
ROCE
2%
ROIC
2%
Country DK
Market Cap 3.8T DKK
ROE
88%
ROA
30%
ROCE
79%
ROIC
36%
Country US
Market Cap 389.4B USD
ROE
47%
ROA
20%
ROCE
12%
ROIC
10%
Country US
Market Cap 323.1B USD
ROE
1%
ROA
0%
ROCE
7%
ROIC
1%
Country CH
Market Cap 186.2B CHF
ROE
40%
ROA
13%
ROCE
30%
ROIC
23%
Country CH
Market Cap 184.9B CHF
ROE
28%
ROA
14%
ROCE
16%
ROIC
14%
Country UK
Market Cap 156.1B GBP
ROE
16%
ROA
6%
ROCE
13%
ROIC
11%
Country US
Market Cap 150.8B USD
ROE
2%
ROA
1%
ROCE
8%
ROIC
16%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More